VAERS Explorer
Back to explore

Report #2833006

Received Mar 25, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
MI
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALS1——

Symptoms (1)

Rash

Symptom narrative

a little rash on the neck and upper back; This non-serious case was reported by a physician via call center representative and described the occurrence of rash in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced rash (Verbatim: a little rash on the neck and upper back). The outcome of the rash was unknown. It was unknown if the reporter considered the rash to be related to Shingrix. It was unknown if the company considered the rash to be related to Shingrix. Additional Information: GSK Receipt Date : 20-MAR-2025 Medical doctor called to informed that patient got the first dose of Shingrix in a pharmacy (unknown date and location) and after the administration developed a little rash on the neck and upper back. Reporter questioned that could the patient received the 2nd dose still.